Poxviral vaccine extends survival in prostate cancer

29 January 2010 | by Nicola Garrett Print this article Comments Share this article
Patients with metastatic prostate cancer who received a vaccine of weakened poxviruses lived substantially longer than patients who received a placebo vaccine, researchers report....

Want to read complete article? Please Sign in or Register.

Journals

Members of Oncology Update can access the following journals for free:

Most viewed articles this week

Recent comments

Related sites